Increasing lifestyle diseases in Spain demand for uncontaminated drug administration using innovative drug delivery devices: Ken Research - PowerPoint PPT Presentation

About This Presentation
Title:

Increasing lifestyle diseases in Spain demand for uncontaminated drug administration using innovative drug delivery devices: Ken Research

Description:

Spain Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices”, large hospitals across the country acquire or merge with medium and small hospitals to enhancing the quality of treatment... For more information on the market research report please refer to the below link: – PowerPoint PPT presentation

Number of Views:43

less

Transcript and Presenter's Notes

Title: Increasing lifestyle diseases in Spain demand for uncontaminated drug administration using innovative drug delivery devices: Ken Research


1
Spain Drug Delivery Devices Market Outlook to
2023 Ken Research
2
The increase in occurrences of chronic diseases
in Spain has triggered a growth in biologics
market, technological advancements and
introduction of new products. The improvement in
efficacy of drug delivery, drug safety along with
controlling the rate of drug delivery, time, and
place of drug release in the body are the major
elements affecting the drug delivery
technologies. Almost all the companies are
manufacturing smart and fast technologies which
offer effective treatments for diseases. Majority
of manufacturing companies are investing huge
funds in the research and development of drug
delivery systems that cater to the needs of
patients for effective delivery of drugs. The
leading players in global drug delivery
technology market are Johnson Johnson, Inc.
(U.S.), F. Hoffman-La Roche (Switzerland), Merck
Co., Inc. (U.S.), Bayer AG (Germany), Pfizer,
Inc. (U.S.), Novartis AG (Switzerland), 3M
Company (U.S.), Becton, Dickinson and Company
(U.S.), GlaxoSmithKline plc, (U.K.), Sanofi
(France), and Antares Pharma, Inc. (U.S.).
3
The applications of drug delivery devices are at
hospitals, ambulatory surgical centers, home care
settings, diagnostic centers, other facilities
such as medical data centers, research and
clinical laboratories. Drug Delivery devices are
used to administer medical drugs via Oral,
Injectable, Topical, Ocular, Nasal, Pulmonary,
Transmucosal, and Implantable. The introduction
of central venous catheters (CVCs) in Spain has
created healthcare reforms with a positive impact
and safety. It was observed that CVCs are the
best practices of using and managing invasive
devices. CVCs prevents and control
healthcare-associated infections in hospitals,
outpatient settings, and home healthcare settings
along with associated complications. These key
factors led to an increased adoption rate of CVCs
in healthcare centres Spain. The increasing
awareness about the antimicrobial technology has
led to increasing adoption of antimicrobial CVCs.
4
The central venous catheters in Spain are
segmented into antimicrobial, non-antimicrobial,
and non-tunneled catheter devices. The
non-tunneled CVCs are also known as subclavian,
percutaneous, and short-term catheters which are
used as an alternative to peripherally inserted
central catheters (PICC). Healthcares
facilitating dialysis procedures for urological
and renal disorders witness an increased influx
of patients and a large requirement of
catheterization. The applications of CVCs are at
multi-specialty hospitals, private hospitals, and
hospital groups. The leading players in the
CVCs in Spain are Teleflex Inc, C. R. Bard Inc,
Edwards Lifesciences Corp and B. Braun Melsungen
AG. The other vendors in central venous catheters
market are Vygon, Cook, Amecath, AngioDynamics,
BACTIGUARD, BD, Biosensors International, Boston
Scientific, CONMED, Guangdong Baihe Medical
Technology, Intra special catheters, isomed,
Kimal, lepumedical, Medical Components, PRODIMED,
SCW MEDICATH, SILMAG, Smiths Medical, Terumo,
TROGE MEDICAL, TUOREN Medical, VOGT MEDICAL, and
ZOLL Medical.
5
According to the study Spain Drug Delivery
Devices Market Outlook to 2023-Central Venous
Catheters, Infusion Systems, Needle Free
Injections and Metered Dose Inhaler Devices,
large hospitals across the country acquire or
merge with medium and small hospitals to
enhancing the quality of treatment. Merging
improves the capital investment, technology, and
infrastructure of the small hospitals. Therefore,
more population will prefer quality treatment
which in turn demands for infusion pumps and
reduces cost. Also, smaller hospitals under the
wings of bigger hospitals provide complicated
treatments and surgeries that involve infusion of
drugs and fluids such as blood and nutrients with
the use of infusion pumps. The infusion pumps
market in Spain will witness a steady growth over
the coming years. The infusion pumps are
manufactured and sold at local and international
levels. The global manufacturers focus on
improved technologies, high-quality products, and
brand image.
6
The increasing demand for infusion pumps and
accessories such as injection port, IV cables,
syringes, air embolism, infiltration, hematoma,
and dose error will have an adverse impact on the
infusion pumps market. The applications of global
infusion pumps are at the ambulatory surgical
centers (ASCs), hospitals, and physicians
offices. Infusion pumps are used in healthcare
facilities to inject fluid drugs, nutrients, and
blood in a controlled manner. The adoption of
infusion pumps in almost all chronic illnesses
and cancer cases is expected rise with modern
lifestyle and is sure to support the growth of
infusion pumps market over the coming
years. Spain infusion systems market is
segmented into ambulatory infusion pumps, enteral
infusion pumps, implantable infusion pumps,
infusion disposable set, syringe pumps and
volumetric pumps. The leading players in Spains
infusion pumps market are Hospira Inc, Becton
Dickinson and Co, Baxter International Inc and
Medtronic plc. The other vendors in the infusion
systems market are Flowonix Medical, InfuSystem,
Moog, Medovex, and Zimmer Biomet.
7
A metered-dose inhaler (MDI) is a device used to
deliver a specific amount of medication to the
lungs. MDI delivers drug in the form of a short
burst of aerosolized medicine through inhalation.
MDI is used to treat asthma, chronic obstructive
pulmonary disease and other respiratory diseases.
With the initiation of macromolecular medications
using metered-dose inhaler the scope of aerosol
drug delivery is expanding to other
non-respiratory illnesses such as diabetes,
analgesia, thyroid disorders, and other genetic
disease. The leading players in Spains
metered-dose inhaler market are GlaxoSmithKline
Plc, AstraZeneca Plc and Boehringer Ingelheim
GmbH. The MDI market in Spain will witness a
steady growth over the coming years. Needle free
injection technology (NFIT) includes a wide range
of drug delivery systems. Drugs are administered
through skin using any of the forces as Lorentz,
Shock waves, pressure by gas or electrophoresis
nullifying the use of needle.
8
This technology is highly useful in mass
immunization programmes. NFIT devices are
classified based on their working, type of load,
mechanism of drug delivery and site of delivery.
The sterility, shelf life and viscosity of drug
are the main components for a stable, safe and an
effective drug dose through NFIT. The NFIT market
in Spain will witness a steady growth over the
coming years. The key factors driving the growth
in drug delivery devices market are increased
prevalence of chronic diseases, technological
advances, increase in individual therapy,
increased understanding about drug metabolism
among the population, and requirement of
controlled drug release. The major challenges
faced by Spains drug delivery devices market are
injuries, infections, high cost and strict
regulatory framework. The various drug delivery
devices in Spain also include injectable,
transdermal, ocular, implantable, oral, nasal,
topic and pulmonary drug delivery devices. The
major players in Spains drug delivery devices
are INJEX Equidyne Systems, Teleflex Inc, B.
Braun Melsungen AG, Bioject Medical Technologies
Inc, GlaxoSmithKline Plc, Baxter International
Inc, Edwards Lifesciences Corp, Antares Pharma
Inc,
9
AstraZeneca Plc, Boehringer Ingelheim GmbH,
Fresenius Kabi AG, Pfizer Inc, Merck Co Inc,
Becton Dickinson and Co, C. R. Bard Inc, Smiths
Medical, Terumo Corp, Teva Pharmaceutical
Industries Ltd, Medtronic Plc and Hospira Inc.
Overall, the drug delivery devices market in
Spain is expected to grow steadily over the
coming years. Key Topics Covered in the
Report Spain Drug Delivery Devices Market
Research Spain Drug Delivery Devices Market
Size Infusion Pumps Market In Spain Spain Needle
Free Injection Technology Metered-Dose Inhaler
(MDI) Market in Spain Needle Free Injection
Technology (NFIT) Market in Spain Central Venous
Catheters Demand in Spain Global Drug Delivery
Technology Market Research Johnson Johnson
Market Share In Spain Merck Co., Inc Market
Share In Spain
10
For more information on the market research
report please refer to the below
link https//www.kenresearch.com/healthcare/medic
al-devices/spain-drug-delivery-devices/135988-91.h
tml Related Reports Canada Drug Delivery
Devices Market Outlook to 2023-Central Venous
Catheters, Infusion Systems, Needle Free
Injections and Metered Dose Inhaler Devices
Brazil Drug Delivery Devices Market Outlook to
2023-Central Venous Catheters, Infusion Systems,
Needle Free Injections and Metered Dose Inhaler
Devices Contact Us Ken Research Ankur Gupta,
Head Marketing Communications sales_at_kenresearch.
com 0124-4230204
Write a Comment
User Comments (0)
About PowerShow.com